Correlation of obesity and osteoporosis: Effect of free fatty acids on bone marrow-derived mesenchymal stem cell differentiation.

Studies on the relationship between obesity and bone have recently become widespread. The aim of this study was to investigate the effect of obesity on bone, utilizing a diet-induced obese mouse model, and to explore the role of free fatty acids (FFAs) in the osteogenesis/adipogenesis of mouse bone marrow-derived mesenchymal stem cells (BMSCs). An obese mouse model was established by a high-fat diet (HFD). Proximal femurs were collected at sacrifice, and bone mineral density (BMD) in the proximal femurs was measured by dual-energy X-ray absorptiometry. Bone histomorphometry was performed using undecalcified sections of the proximal femurs. The effect of obesity on the differentiation of mouse BMSCs was assessed by colony formation assays and gene expression analysis. In vitro, various osteogenic and adipogenic genes were determined by real-time quantitative PCR in mouse BMSCs after exposure to conditioned medium (CM) from FFA-treated 3T3-L1 adipocytes. Western blotting was further performed to analyze the representative protein expression of PPARγ and Runx2. BMD and trabecular thickness were significantly greater in the HFD mice than in the control mice. CFU-osteo assay showed significantly increased osteogenesis of BMSCs. The mRNA level of Runx2 was significantly higher, while PPARγ and Pref-1 were significantly lower in BMSCs from the HFD mice compared to the control mice. In mouse BMSCs, the Sox9 and Runx2 genes were significantly up-regulated after exposure to CM from FFA-treated adipocytes, while PPARγ and CEBP-α were significantly down-regulated. Osteogenesis was significantly increased, while adipogenesis was significantly decreased. In conclusion, HFD-induced obesity may play a protective role in bone formation by concomitantly promoting osteogenic and suppressing adipogenic differentiation of BMSCs through factors secreted by FFA-treated adipocytes.

[1]  S. Mittelman,et al.  Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. , 2009, The Journal of clinical endocrinology and metabolism.

[2]  A. Grey Fatty Acids and Bone , 2009 .

[3]  I. Reid,et al.  Modulation of osteoclastogenesis by fatty acids. , 2008, Endocrinology.

[4]  I. Reid Relationships between fat and bone , 2008, Osteoporosis International.

[5]  D. Drucker,et al.  The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. , 2008, Endocrinology.

[6]  H. Deng,et al.  Correlation of Obesity and Osteoporosis: Effect of Fat Mass on the Determination of Osteoporosis , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  H. Xie,et al.  Adiponectin Stimulates RANKL and Inhibits OPG Expression in Human Osteoblasts Through the MAPK Signaling Pathway , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  J. Tobias,et al.  Adipose tissue stimulates bone growth in prepubertal children. , 2006, The Journal of clinical endocrinology and metabolism.

[9]  L. Raisz Pathogenesis of osteoporosis: concepts, conflicts, and prospects. , 2005, The Journal of clinical investigation.

[10]  K. Gumireddy,et al.  Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. , 2005, Diabetes.

[11]  H. Matsushime,et al.  Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. , 2005, Biochemical and biophysical research communications.

[12]  R. Baumgartner,et al.  Cytokine-related aging process. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[13]  M. Uchiyama,et al.  Obese Japanese children have low bone mineral density after puberty , 2004, Journal of Bone and Mineral Metabolism.

[14]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[15]  L. Melton,et al.  Adverse Outcomes of Osteoporotic Fractures in the General Population , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  I. Reid Relationships among body mass, its components, and bone. , 2002, Bone.

[17]  R. Thieringer,et al.  Peroxisome Proliferator-activated Receptor-γ Ligands Inhibit Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity* , 2001, The Journal of Biological Chemistry.

[18]  B. Watkins,et al.  Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. , 2000, The Journal of nutrition.

[19]  C. Steppan,et al.  Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.

[20]  K. Nakao,et al.  Downregulation of leptin by free fatty acids in rat adipocytes: effects of triacsin C, palmitate, and 2-bromopalmitate. , 2000, Metabolism: clinical and experimental.

[21]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[22]  Sheila M. Williams,et al.  Bone Mineral Density in Girls with Forearm Fractures , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  C. Devlin,et al.  Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. , 1992, Journal of cell science.

[24]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987 .

[25]  大島 和也 Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast , 2007 .

[26]  Cl ´ õnica Intracellular signalling pathways activated by leptin , 2006 .